Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

T-cell repertoire analysis and metrics of diversity and clonality
Johanna Chiffelle, Raphaël Genolet, Marta A. S. Perez, et al.
Current Opinion in Biotechnology (2020) Vol. 65, pp. 284-295
Open Access | Times Cited: 133

Showing 1-25 of 133 citing articles:

T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma
Alexander X. Lozano, Aadel A. Chaudhuri, Aishwarya Nene, et al.
Nature Medicine (2022) Vol. 28, Iss. 2, pp. 353-362
Open Access | Times Cited: 204
Transitioning single-cell genomics into the clinic
Jennifer Lim, Venessa Chin, Kirsten A. Fairfax, et al.
Nature Reviews Genetics (2023) Vol. 24, Iss. 8, pp. 573-584
Closed Access | Times Cited: 47
Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer
Daniiar Dyikanov, A. V. Zaitsev, Т.В. Васильева, et al.
Cancer Cell (2024) Vol. 42, Iss. 5, pp. 759-779.e12
Open Access | Times Cited: 23
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
Justin F. Gainor, Manish R. Patel, Jeffrey S. Weber, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2209-2223
Closed Access | Times Cited: 17
Integrating single-cell RNA and T cell/B cell receptor sequencing with mass cytometry reveals dynamic trajectories of human peripheral immune cells from birth to old age
Yufei Wang, Ronghong Li, Renyang Tong, et al.
Nature Immunology (2025)
Open Access | Times Cited: 6
Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer
Jason M. Link, Jennifer Eng, Carl Pelz, et al.
Nature Cancer (2025)
Open Access | Times Cited: 2
Clonally expanded CD8 T cells characterize amyotrophic lateral sclerosis-4
Laura Campisi, Shahab Chizari, Jessica Ho, et al.
Nature (2022) Vol. 606, Iss. 7916, pp. 945-952
Open Access | Times Cited: 59
Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer
Aislyn Schalck, Donastas Sakellariou-Thompson, Marie‐Andrée Forget, et al.
Cancer Discovery (2022) Vol. 12, Iss. 10, pp. 2330-2349
Open Access | Times Cited: 50
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma
Chelsea Taylor, Robert Watson, Orion Tong, et al.
Nature Medicine (2022) Vol. 28, Iss. 12, pp. 2592-2600
Open Access | Times Cited: 46
Evaluation of the TCR Repertoire as a Predictive and Prognostic Biomarker in Cancer: Diversity or Clonality?
Andrea Aran, Laia Garrigós, Giuseppe Curigliano, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1771-1771
Open Access | Times Cited: 41
Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency
Anirban Das, Uri Tabori, Lauren C. Sambira Nahum, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 23, pp. 4770-4783
Open Access | Times Cited: 34
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs
Raphaël Genolet, Sara Bobisse, Johanna Chiffelle, et al.
Cell Reports Methods (2023) Vol. 3, Iss. 4, pp. 100459-100459
Open Access | Times Cited: 23
Adaptive immune receptor repertoire analysis
Vanessa Mhanna, Habib Bashour, Khang Lê Quý, et al.
Nature Reviews Methods Primers (2024) Vol. 4, Iss. 1
Closed Access | Times Cited: 12
Merkel cell polyomavirus-specific and CD39+CLA+ CD8 T cells as blood-based predictive biomarkers for PD-1 blockade in Merkel cell carcinoma
Heeju Ryu, Timothy Bi, Thomas H. Pulliam, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101390-101390
Open Access | Times Cited: 11
Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility
Shravan Leonard‐Murali, Chetana Bhaskarla, Ghanshyam S. Yadav, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms
Rémy Pétremand, Johanna Chiffelle, Sara Bobisse, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 9
Optimizing TIL therapy for uveal melanoma: lessons learned and unlearned from cutaneous melanoma
Shravan Leonard‐Murali, Udai S. Kammula
Immunotherapy (2025), pp. 1-9
Open Access | Times Cited: 1
T-cell repertoire diversity: friend or foe for protective antitumor response?
Nicla Porciello, Ornella Franzese, Lorenzo D’Ambrosio, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 38
TCR-sequencing in cancer and autoimmunity: barcodes and beyond
Kristen E. Pauken, Kaitlyn A. Lagattuta, Benjamin Y. Lu, et al.
Trends in Immunology (2022) Vol. 43, Iss. 3, pp. 180-194
Open Access | Times Cited: 36
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer
L. Mazzotti, Anna Gaimari, Sara Bravaccini, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8590-8590
Open Access | Times Cited: 28
Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies
Shengkang Huang, Xinyu Wang, Yu Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 19
DeepAIR: A deep learning framework for effective integration of sequence and 3D structure to enable adaptive immune receptor analysis
Yu Zhao, Bing He, Fan Xu, et al.
Science Advances (2023) Vol. 9, Iss. 32
Open Access | Times Cited: 19
Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humans
Fan Lin, Junwei Liu, Wei Hu, et al.
Cell Research (2024) Vol. 34, Iss. 6, pp. 407-427
Open Access | Times Cited: 8
Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma
Peter Thuss‐Patience, Anica Högner, Eray Goekkurt, et al.
JAMA Network Open (2024) Vol. 7, Iss. 1, pp. e2352830-e2352830
Open Access | Times Cited: 7
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma
Johanna Chiffelle, David Barras, Rémy Pétremand, et al.
Immunity (2024)
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top